Internal Medicine, Endocrinology, Diabetes, & Metabolism · Nashville, TN
NPI
1851488985
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3601 Tvc
Nashville, TN, 37232
Phone (615) 322-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$26K
299 services
Medicare patients, 2024
247
Average age 71
Drug cost, 2024
$21.9M
760 prescriptions
Company payments, 2025
$61K
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kathryn Dahir was code 99215 (office e&m - established), 213 times for 190 patients. In total Kathryn Dahir billed 299 services in 8 codes, and Medicare paid $26K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 213 | 190 | $94.33 | $20K |
| 99214 Office E&M - Established | Facility | 34 | 34 | $58.77 | $1,998 |
| 99222 Hospital E&M - Initial | Facility | 12 | 12 | $100.05 | $1,201 |
By year: 2022 $25K for 364 services; 2023 $27K for 323 services; 2024 $26K for 299 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 15 | 13 | $2.95 | $44.19 |
Medicare prescription drug claims, 2024
In 2024, the drug Kathryn Dahir prescribed most often to Medicare patients was Tymlos (Abaloparatide), with 153 prescriptions and refills. In total Kathryn Dahir wrote 760 Medicare prescriptions that cost $21.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tymlos Abaloparatide | 153 | 181 | 22 | $448K |
| Strensiq Asfotase Alfa | 153 | 157 | 12 | $20.0M |
| Levothyroxine Sodium Generic | 92 | 246 | 27 | $718 |
| Teriparatide Generic | 64 | 65 | Under 11 | $158K |
| Forteo Teriparatide | 48 | 56 | Under 11 | $233K |
| Crysvita Burosumab-Twza | 46 | 46 | Under 11 | $994K |
| Synthroid Levothyroxine Sodium | 39 | 93 | 11 | $2,455 |
| Alendronate Sodium Generic | 30 | 85 | Under 11 | $251 |
| Calcitriol Generic | 27 | 73 | Under 11 | $902 |
| Methylprednisolone Generic | 14 | 14 | 13 | $127 |
| Liothyronine Sodium Generic | 12 | 12 | Under 11 | $109 |
Brand drugs: 572 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kathryn Dahir $61K ($61K in general payments such as food, travel and fees) from 8 companies. The largest payer was Alexion Pharmaceuticals, Inc. with $24K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.